Ernesto Vigna Selected Research

COVID-19

7/2023

Safe and Effective Administration of Caplacizumab in COVID-19-Associated Thrombotic Thrombocytopenic Purpura.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ernesto Vigna Research Topics

Disease

22	Multiple Myeloma 05/2024 - 05/2013
14	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2024 - 03/2008
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 09/2016
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2024 - 04/2004
5	Neoplasms (Cancer) 05/2024 - 03/2017
4	Anemia 04/2024 - 09/2008
4	Residual Neoplasm 04/2024 - 01/2015
4	Disease Progression 01/2024 - 04/2011
3	Primary Myelofibrosis (Myelosclerosis) 04/2024 - 01/2011
3	Leukemia 01/2024 - 01/2015
3	Thrombotic Thrombocytopenic Purpura 07/2023 - 04/2018
2	Thrombocytopenia (Thrombopenia) 10/2021 - 04/2018
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2017 - 03/2014
1	Sudden Death 01/2024
1	Heart Failure 01/2024
1	Infections 01/2024
1	Hemorrhage 01/2024
1	Thrombotic Microangiopathies 07/2023
1	COVID-19 07/2023
1	Hyperplasia 05/2023
1	Iron Overload 05/2023
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 10/2021
1	Philadelphia Chromosome 07/2021
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2020
1	Ischemia 04/2018
1	Hemolytic Anemia 04/2018
1	Neutropenia 11/2017
1	Body Weight (Weight, Body) 07/2017
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2017
1	Fibrosis (Cirrhosis) 01/2017
1	B-Cell Lymphoma (Lymphoma, B Cell) 06/2015
1	Smoldering Multiple Myeloma 04/2015

Drug/Important Bio-Agent (IBA)

13	Lenalidomide (CC 5013)FDA Link 01/2024 - 02/2011
9	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 09/2008
6	elotuzumabIBA 01/2023 - 01/2021
5	Rituximab (Mabthera)FDA Link 04/2021 - 09/2008
5	Dasatinib (BMS 354825)FDA Link 01/2020 - 03/2014
4	ibrutinibIBA 01/2024 - 01/2021
4	Immunomodulating AgentsIBA 10/2023 - 06/2013
4	Proteasome InhibitorsIBA 10/2023 - 06/2013
4	Bendamustine Hydrochloride FDA Link 01/2021 - 11/2013
4	Proteins (Proteins, Gene)FDA Link 04/2015 - 03/2008
3	thiamine triphosphorate (TTP)IBA 07/2023 - 04/2018
3	carfilzomibIBA 12/2022 - 01/2022
3	ponatinibIBA 07/2021 - 01/2017
3	Melphalan (Alkeran)FDA LinkGeneric 03/2017 - 05/2013
2	Monoclonal AntibodiesIBA 05/2024 - 10/2023
2	caplacizumabIBA 07/2023 - 04/2023
2	Deferasirox FDA Link 05/2023 - 06/2014
2	venetoclaxIBA 01/2023 - 11/2017
2	acalabrutinibIBA 01/2023 - 01/2020
2	pomalidomideIBA 01/2023 - 01/2017
2	Hemoglobins (Hemoglobin)IBA 07/2017 - 09/2008
2	Bortezomib (Velcade)FDA Link 03/2017 - 11/2015
2	Imatinib Mesylate (Gleevec)FDA Link 01/2017 - 04/2008
2	SteroidsIBA 01/2017 - 09/2008
1	fms-Like Tyrosine Kinase 3IBA 05/2024
1	CytokinesIBA 04/2024
1	N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA 04/2024
1	Janus Kinase InhibitorsIBA 04/2024
1	blinatumomabIBA 04/2024
1	selinexorIBA 03/2024
1	tagraxofuspIBA 10/2023
1	luspaterceptIBA 10/2023
1	zanubrutinibIBA 09/2023
1	glasdegibIBA 09/2023
1	ivosidenibIBA 09/2023
1	belantamab mafodotinIBA 05/2023
1	DeferiproneIBA 05/2023
1	Chelating AgentsIBA 05/2023
1	Deferoxamine (Desferal)FDA LinkGeneric 05/2023
1	IronIBA 05/2023
1	Azacitidine (5 Azacytidine)FDA Link 04/2023
1	isatuximabIBA 01/2023
1	Inosine Triphosphate (ITP)IBA 10/2021
1	eltrombopag FDA Link 10/2021
1	Tyrosine Kinase InhibitorsIBA 07/2021
1	idelalisibIBA 04/2021
1	eculizumab FDA Link 04/2018
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2018
1	Prednisone (Sone)FDA LinkGeneric 03/2017
1	PanobinostatIBA 09/2016
1	Sorafenib (BAY 43-9006)FDA Link 06/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2016
1	Thalidomide (Thalomid)FDA Link 11/2015
1	betaglycan (TGFBR3)IBA 08/2015
1	Histone Deacetylase InhibitorsIBA 06/2015
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 06/2015
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2015
1	fludarabineIBA 06/2015
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 06/2015
1	Chimeric Antigen ReceptorsIBA 06/2015
1	ixazomibIBA 01/2015

Therapy/Procedure

19	Therapeutics 05/2024 - 04/2008
6	Drug Therapy (Chemotherapy) 10/2023 - 05/2013
4	Salvage Therapy 12/2022 - 01/2021
3	Stem Cell Transplantation 11/2015 - 04/2004
1	Homologous Transplantation 07/2021
1	Hematopoietic Stem Cell Mobilization 03/2021
1	Hematopoietic Stem Cell Transplantation 01/2020